Press releases
- Exact Sciences to Participate in June Investor Conferences
- Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®
- Exact Sciences Earns 2024 Great Place To Work® Certification™
- Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy
- Exact Sciences Announces First-Quarter 2024 Results
- Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024
- Exact Sciences to Participate in May Investor Conference
- Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024
- Exact Sciences Schedules First Quarter 2024 Earnings Call
- Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment
More ▼
Key statistics
As of last trade Exact Sciences Corp (EXAS:DEU) traded at 39.65, 0.25% above its 52-week low of 39.55, set on Jun 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 40.66 |
---|---|
High | 41.46 |
Low | 39.55 |
Bid | 39.66 |
Offer | 39.86 |
Previous close | 40.97 |
Average volume | 222.75 |
---|---|
Shares outstanding | 184.53m |
Free float | 182.72m |
P/E (TTM) | -- |
Market cap | 8.41bn USD |
EPS (TTM) | -1.32 USD |
Data delayed at least 15 minutes, as of Jun 07 2024.
More ▼